To gain insight into the underlying biological consequence of miRNA-23a deregulation in response to muscular atrophy at late time points of atrophy development, we looked at the expression of APAF-1, as well as the main downstream target of the miRNA-23a/APAF-1 axis of regulation, Caspase 9. The gene discussed is CASP9; the disease is muscular atrophy.